Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
BeOne Medicines
Eli Lilly and Company
BeOne Medicines
Eli Lilly and Company
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
BeOne Medicines
University of Arizona
Boryung Pharmaceutical Co., Ltd
Universität des Saarlandes
Incyte Corporation
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of California, Davis
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
International Extranodal Lymphoma Study Group (IELSG)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
AstraZeneca
Stanford University
Xencor, Inc.
BeiGene
BeiGene
Stanford University
University of Rochester
Calibr, a division of Scripps Research
City of Hope Medical Center
Shanghai YingLi Pharmaceutical Co. Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
Celldex Therapeutics
University of Colorado, Denver
University Hospital Southampton NHS Foundation Trust
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Mayo Clinic
University of Nebraska
University of Nebraska
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Children's Oncology Group
Agenus Inc.